Cardiovascular medicine
Is there a role for renin profiling in selecting chronic heart
failure patients for ACE inhibitor treatment?
P O Lima, R J MacFadyenb, A D Struthersa
a Cardiovascular
Research Group, Department of Clinical Pharmacology and Therapeutics,
University of Dundee, Ninewells Hospital and Medical School, Dundee
DD1 9SY, UK, b Cardiac Unit (Floor 7), Raigmore Hospital,
Inverness IV2 3UJ, UK
Correspondence to: Dr Lim email: pitt{at}clinpharm.dundee.ac.uk
Accepted 5 November
1999
BACKGROUND
It remains uncertain whether angiotensin
converting enzyme (ACE) inhibitors benefit all heart failure patients
or just those with renin-angiotensin-aldosterone system (RAAS) activation.
OBJECTIVE
To determine whether the response to an ACE
inhibitor, assessed by urine sodium excretion, was different in
patients with low renin versus those with high renin.
DESIGN
Plasma renin activity (PRA) was measured in 38 patients with stable chronic heart failure (21 male, 17 female; mean
(SD) age 71 (6) years, range 59-82 years) on chronic diuretic
treatment alone. They were divided into three groups: low (PRA
1.5
ng/ml/h, n = 11); normal (1.5 < PRA < 5, n = 14); and high
(PRA > 5, n = 13). The effect of ACE inhibition was then assessed
on diuretic induced natriuresis with respect to renin status.
RESULTS
There were no significant differences in age and
sex distribution between the groups. Plasma angiotensin II and
aldosterone increased serially from low to high renin groups, while
24 h urinary sodium concentrations fell from low to high renin
groups (low PRA, 96.7 (39.5); normal PRA, 90.4 (26.7); high PRA, 66.3 (18.9) mmol/l; p = 0.033), despite a higher diuretic dose in the high renin group. This blunted natriuretic effect of loop diuretics was
caused by RAAS activation, which could partly be reversed by ACE
inhibition. ACE inhibitors increased natriuresis by 22% in the high
renin group (p = 0.029), but had no effect in the normal and low
renin groups. Within the low renin group, five of the 11 patients had
persistently low renin levels despite ACE inhibition. There was a
non-significant reduction in natriuresis (
9.6%, p = 0.335)
following ACE inhibition in this subgroup of patients.
CONCLUSIONS
About one third of heart failure patients in
our study had low renin status and a non-activated RAAS, despite
diuretic treatment. ACE inhibitors did not alter natriuresis
significantly in this subgroup of patients, and enhanced natriuresis
only in patients with high renin. There is thus tentative support for
renin profiling in targeting ACE inhibitors to the most deserving, by
showing that short term sodium retention does not occur in low renin
patients if ACE inhibitors are withdrawn.
Keywords: chronic heart failure; renin profiling; ACE inhibition; urinary sodium excretion
© 2000 by Heart
This article has been cited by other articles:
-
Lainchbury, J. G., Troughton, R. W., Frampton, C. M., Yandle, T. G., Hamid, A., Nicholls, M. G., Richards, A. M.
(2006). NTproBNP-guided drug treatment for chronic heart failure: design and methods in the "BATTLESCARRED" trial. Eur J Heart Fail
8: 532-538
[Abstract] [Full Text] -
Berezin, A. E
(2001). Losartan in the Therapy of Heart Failure Patients. Asian Cardiovasc. Thorac. Ann.
9: 302-307
[Abstract] [Full Text] -
Oxenham, H., Sharpe, N.
(2000). Prognostic stratification in heart failure: what's the point?. Eur Heart J
21: 1815-1816
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
